1. Home
  2. NCNA vs HKPD Comparison

NCNA vs HKPD Comparison

Compare NCNA & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NuCana plc

NCNA

NuCana plc

HOLD

Current Price

$1.11

Market Cap

5.5M

Sector

Health Care

ML Signal

HOLD

HKPD

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

N/A

Current Price

$0.10

Market Cap

6.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NCNA
HKPD
Founded
1997
2016
Country
United Kingdom
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Pharmaceuticals
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5M
6.2M
IPO Year
2017
2024

Fundamental Metrics

Financial Performance
Metric
NCNA
HKPD
Price
$1.11
$0.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
56.4K
★ 921.6K
Earning Date
11-12-2026
08-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.01
$0.10
52 Week High
$6.16
$1.68

Technical Indicators

Market Signals
Indicator
NCNA
HKPD
Relative Strength Index (RSI) 36.11 24.26
Support Level N/A N/A
Resistance Level $1.40 $0.70
Average True Range (ATR) 0.09 0.01
MACD -0.02 0.01
Stochastic Oscillator 28.97 2.07

Price Performance

Historical Comparison
NCNA
HKPD

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.

About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

Cellyan Biotechnology Co Ltd is an integrated pharmaceutical cross-border e-commerce supply chain service provider with a professional team and related pharmaceutical storage facilities in Hong Kong. It operates through two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, referred to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, referred to as the Procurement and Distribution division. Its main business provides one-stop services for merchants engaged in cross-border pharmaceutical e-commerce, including OTC wholesale, import and export, warehousing, packaging, customs clearance and delivery to final destinations, forming a closed loop of pharmaceutical cross-border e-commerce supply chain.

Share on Social Networks: